DIP Episode 294 - NBME Gastroenterology Series 2 (for all USMLEs)

Source / episode info

• Episode: 294
• Title: Divine Intervention Episode 294 – NBME Gastroenterology Series 2 (for all USML Es).
• Published: 2021-03-12
• Source: Episode page

One-liner

This episode provides a comprehensive review of GI pathology, covering celiac disease (duodenum/jejunum involvement), Crohn's disease (terminal ileum involvement), the pathophysiology and management of GERD, PPI indications for stress ulcers, Barrett's esophagus risk stratification, and Dapsone use in leprosy.

High-yield summary

• Celiac Disease: Characterized by villous atrophy, intraepithelial lymphocytosis, anti-tTG IgA, and HLA-DQ2/HLA-DQ8 association; typically affects the duodenum and jejunum.
• Crohn's vs Celiac: Crohn's disease classically involves the terminal ileum (leading to B12 deficiency and increased oxalate absorption risk); celiac disease spares the terminal ileum.
• PPI Use: PP Is are critical for prophylaxis in severe burns, high intracranial pressure (ICP), or chronic steroid use due to their ability to inhibit H+/K+ AT Pase pumps, preventing stress/Cushing's ulcers.
• GERD Management: Initial management involves lifestyle changes and a therapeutic trial of PP Is; if symptoms persist, EGD is required, but for older patients (>50) with long-standing GERD, skip the initial PPI trial and proceed directly to EGD.
• Barrett's Esophagus: Represents intestinal metaplasia (goblet cells) in the lower esophagus due to chronic acid exposure; this condition significantly increases the risk of esophageal adenocarcinoma.
• Dapsone Therapy: Used for dermatitis/erythrodermic lupus, prophylaxis against Pneumocystis pneumonia (PCP), and is a core component of triple therapy for leprosy (with Rifampin and Clofazimine).

Learning objectives

• Differentiate the clinical and pathological findings between Celiac disease and Crohn's disease.
• Apply knowledge of PPI indications for prophylaxis in various high-risk states (burns, ICP, steroids).
• Interpret endoscopic findings suggestive of Barrett's esophagus and understand its associated malignancy risk.
• Outline the appropriate diagnostic workup sequence for chronic GERD symptoms.
• Recall the mechanism of action and clinical uses of Dapsone in infectious disease and dermatology.

Board exam buzzwords

Rapid review table

Board-speak -> diagnosis

Differential diagnosis / distinguishing features

GERD vs Barrett's Esophagus

PPI Indications

Management pearls

• PPI Use: Always consider prophylactic PP Is in patients undergoing major surgery or those with severe systemic stress (e.g., trauma, sepsis) due to the risk of developing stress ulcers/Cushing's ulcers.
• GERD Workup Age Cutoff: For patients over 50 years old presenting with chronic GERD symptoms, do not delay diagnosis by initiating a PPI trial; proceed directly to EGD.
• Barrett's Risk Stratification: The presence of intestinal metaplasia (goblet cells) is the key finding that mandates surveillance due to increased risk of adenocarcinoma.
• Leprosy Treatment: Standard treatment requires combination therapy: Dapsone, Rifampin, and Clofazimine for 24 months.

Don't miss

Integration & clinical reasoning

• GI/Endocrinology Integration: The use of chronic steroids requires prophylactic PP Is and bismuth supplementation because steroids increase peptic ulcer risk and inhibit osteoblasts (leading to osteoporosis).
• Pharmacology/Gastroenterology Integration: Proton pump inhibitors are the most powerful acid suppressants, making them essential for managing both stress ulcers and hypersecretory states like ZES.
• Pathophysiology/Immunology Integration: Celiac disease is a T-cell mediated autoimmune response triggered by gluten in genetically susceptible individuals (HLA-DQ2/DQ8).

OMM / COMLEX integration

• Acute/Unstable Management Priority: In any acute abdominal presentation (e.g., severe burn, septic shock), standard emergency management takes absolute priority over OMT.
• GI Bleeding: If GI bleeding occurs in an unstable patient, resuscitation and stabilization are paramount; endoscopy is deferred until the patient is hemodynamically stable.

Concept connections / cross-references

• For detailed information on the pathophysiology of inflammatory bowel diseases, see [Episode 15].
• For general GI anatomy and histology review, see [Episode 37].

High-yield association table

Key terms glossary

Study optimization

Question pattern recognition

• Pattern: Malabsorption + Villous Atrophy + Anti-tTG IgA -> Celiac Disease (The classic triad).
• Pattern: Chronic diarrhea + Terminal Ileum involvement + Nephrolithiasis/B12 deficiency -> Crohn's Disease.
• Pattern: GERD symptoms in an elderly patient (>50) who has failed PPI therapy -> Skip the initial PPI trial and proceed directly to EGD.

Test yourself

Common mistakes to avoid

Common traps